Omega Healthcare Investors, Inc. (NYSE:OHI – Get Free Report) CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the sale, the chief financial officer now owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.
Omega Healthcare Investors Stock Performance
Shares of OHI stock opened at $39.98 on Friday. The company has a quick ratio of 5.79, a current ratio of 5.79 and a debt-to-equity ratio of 1.19. Omega Healthcare Investors, Inc. has a 52 week low of $27.53 and a 52 week high of $41.53. The stock has a market capitalization of $10.31 billion, a PE ratio of 36.02, a P/E/G ratio of 1.30 and a beta of 1.00. The firm has a 50 day moving average of $39.04 and a two-hundred day moving average of $34.55.
Omega Healthcare Investors (NYSE:OHI – Get Free Report) last issued its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 EPS for the quarter, missing the consensus estimate of $0.65 by ($0.20). Omega Healthcare Investors had a net margin of 33.52% and a return on equity of 8.61%. The business had revenue of $252.70 million during the quarter, compared to analysts’ expectations of $205.92 million. During the same period in the prior year, the business earned $0.74 EPS. The business’s quarterly revenue was up 17.5% on a year-over-year basis. On average, research analysts predict that Omega Healthcare Investors, Inc. will post 2.69 EPS for the current fiscal year.
Omega Healthcare Investors Announces Dividend
Institutional Investors Weigh In On Omega Healthcare Investors
Several institutional investors have recently modified their holdings of OHI. Versant Capital Management Inc purchased a new stake in shares of Omega Healthcare Investors during the 2nd quarter worth $26,000. WFA Asset Management Corp purchased a new stake in shares of Omega Healthcare Investors during the 1st quarter worth $39,000. Covestor Ltd lifted its position in shares of Omega Healthcare Investors by 47.6% during the 1st quarter. Covestor Ltd now owns 1,337 shares of the real estate investment trust’s stock worth $42,000 after purchasing an additional 431 shares during the last quarter. Highlander Capital Management LLC lifted its position in shares of Omega Healthcare Investors by 52.0% during the 1st quarter. Highlander Capital Management LLC now owns 1,900 shares of the real estate investment trust’s stock worth $60,000 after purchasing an additional 650 shares during the last quarter. Finally, GAMMA Investing LLC raised its stake in Omega Healthcare Investors by 93.4% during the 2nd quarter. GAMMA Investing LLC now owns 2,446 shares of the real estate investment trust’s stock worth $84,000 after acquiring an additional 1,181 shares in the last quarter. 65.25% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of analysts have recently issued reports on the stock. Scotiabank raised their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a report on Monday, August 26th. Truist Financial increased their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research report on Wednesday, September 4th. Wells Fargo & Company reaffirmed an “overweight” rating and set a $43.00 price objective (up previously from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday. Finally, Mizuho cut shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and increased their price objective for the stock from $34.00 to $35.00 in a research report on Thursday, July 25th. Seven equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $36.00.
Check Out Our Latest Research Report on Omega Healthcare Investors
Omega Healthcare Investors Company Profile
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.
See Also
- Five stocks we like better than Omega Healthcare Investors
- How to Capture the Benefits of Dividend Increases
- When Is the Best Time to Invest in Mutual Funds?
- Investing In Preferred Stock vs. Common Stock
- Is NVIDIA Stock in a Correction or Consolidation?
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- 3 Oversold Stocks with Big RSI Rebound Potential
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.